Enzymatic deglycation of proteins

被引:66
作者
Wu, XL [1 ]
Monnier, VM [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1016/j.abb.2003.08.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Reducing sugars such as glucose react with amino groups in proteins to form the Amadori product, which can undergo a wide range of chemical modifications and form cross-links in tissue proteins. There is growing evidence to suggest that accumulation of glycation products is associated with aging and disease progression, as in diabetes. Thus, the design and discovery of inhibitors for the glycation cascade would potentially offer a promising therapeutic approach for the prevention of glycation related diseases, especially diabetes. Two types of enzymes, fructosyl lysine oxidase and fructose lysine 3-phosphokinase, catalyze the deglycation reaction and generate free amine groups. This paper reviews the biochemical properties of these "amadoriase" enzymes, such as structural-function relationship, kinetic mechanism, and substrate specificity, as well as their biological roles and applications in the protein deglycation (C) 2003 Published by Elsevier Inc.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 63 条
[1]
AHMED MU, 1986, J BIOL CHEM, V261, P4889
[2]
Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[3]
ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]
Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine [J].
Booth, AA ;
Khalifah, RG ;
Hudson, BG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) :113-119
[5]
In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs) - Novel inhibition of post-Amadori glycation pathways [J].
Booth, AA ;
Khalifah, RG ;
Todd, P ;
Hudson, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5430-5437
[6]
GLYCOSYLATION PRODUCTS AS TOXIC MEDIATORS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1991, 42 :159-166
[7]
LILLY LECTURE 1993 - GLYCATION AND DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES, 1994, 43 (06) :836-841
[8]
STI35, A STRESS-RESPONSIVE GENE IN FUSARIUM SPP [J].
CHOI, GH ;
MAREK, ET ;
SCHARDL, CL ;
RICHEY, MG ;
CHANG, SY ;
SMITH, DA .
JOURNAL OF BACTERIOLOGY, 1990, 172 (08) :4522-4528
[9]
AMELIORATION OF DIABETIC NEPHROPATHY BY TREATMENT WITH MONOCLONAL-ANTIBODIES AGAINST GLYCATED ALBUMIN [J].
COHEN, MP ;
HUD, E ;
WU, VY .
KIDNEY INTERNATIONAL, 1994, 45 (06) :1673-1679
[10]
DeGroot J, 1999, ARTHRITIS RHEUM, V42, P1003, DOI 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO